Literature DB >> 11791020

The neurohormonal natural history of essential hypertension: towards primary or tertiary aldosteronism?

Pitt O Lim1, Allan D Struthers, Thomas M MacDonald.   

Abstract

Use of the aldosterone-to-renin ratio has controversially suggested that approximately 10% of hypertensives have primary aldosteronism, and most of these individuals are thought to have idiopathic hyperaldosteronism. The usual renin-angiotensin system control is intact in these individuals and is similar to that in low renin and essential hypertensives, differing only in the degree of sensitivity. There is recent evidence suggesting that hyperaldosteronism relates to aldosterone synthase genetic polymorphism, and also that increased angiotensin II stimulation of the adrenal glands appears to paradoxically upregulate the receptors increasing angiotensin II sensitivity. Taken together, the possibility arises that, in susceptible hypertensives, hyperaldosteronism could be acquired. Indeed, it is well known that renin-driven renovascular hypertension is associated with the development of hyperaldosteronism. Hypothetically, within the wider hypertensive population, these findings set the scene that angiotensin II adrenal sensitivity increases over time until the secretion of aldosterone becomes "autonomous" and hence "tertiary" aldosteronism in a significant proportion of hypertensives.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11791020     DOI: 10.1097/00004872-200201000-00003

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  7 in total

Review 1.  Mechanisms of hypertension: the expanding role of aldosterone.

Authors:  E Marie Freel; John M C Connell
Journal:  J Am Soc Nephrol       Date:  2004-08       Impact factor: 10.121

2.  Low-renin hypertension with relative aldosterone excess is associated with impaired NO-mediated vasodilation.

Authors:  Stephen J Duffy; Elizabeth S Biegelsen; Robert T Eberhardt; David F Kahn; Bronwyn A Kingwell; Joseph A Vita
Journal:  Hypertension       Date:  2005-09-19       Impact factor: 10.190

Review 3.  Aldosterone and arterial hypertension.

Authors:  Andreas Tomaschitz; Stefan Pilz; Eberhard Ritz; Barbara Obermayer-Pietsch; Thomas R Pieber
Journal:  Nat Rev Endocrinol       Date:  2009-12-22       Impact factor: 43.330

4.  TASK-3 channel deletion in mice recapitulates low-renin essential hypertension.

Authors:  Nick A Guagliardo; Junlan Yao; Changlong Hu; Elaine M Schertz; David A Tyson; Robert M Carey; Douglas A Bayliss; Paula Q Barrett
Journal:  Hypertension       Date:  2012-04-09       Impact factor: 10.190

Review 5.  Aldosterone: a risk factor for vascular disease.

Authors:  Mario Fritsch Neves; Ernesto L Schiffrin
Journal:  Curr Hypertens Rep       Date:  2003-02       Impact factor: 5.369

6.  Screening for primary aldosteronism in a cohort of Brazilian patients with resistant hypertension.

Authors:  Armando R Nogueira; Katia V Bloch
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-08       Impact factor: 3.738

7.  NP-59 SPECT/CT imaging in stage 1 hypertensive and atypical primary aldosteronism: a 5-year retrospective analysis of clinicolaboratory and imaging features.

Authors:  Yi-Chun Chen; Jainn-Shiun Chiu; Yuh-Feng Wang
Journal:  ScientificWorldJournal       Date:  2013-10-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.